• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation.撤稿声明:外泌体miR-106a-5p通过FBXW7介导的TRIM24降解加速鼻咽癌进展。
Cancer Sci. 2024 Nov;115(11):3829. doi: 10.1111/cas.16312. Epub 2024 Aug 21.
2
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.撤稿声明:丁,J.,王,X.,高,J. 和宋,T.(2021年),胱抑素SN沉默可消除甲状腺乳头状癌的癌症进展和干细胞特性。《欧洲生物化学学会联合会开放生物学》,11: 2186 - 2197。
FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
3
RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI.撤稿声明:泽布替尼通过抑制ARHI甲基化增强人骨肉瘤细胞凋亡。
Cancer Sci. 2024 Dec;115(12):4080. doi: 10.1111/cas.16346. Epub 2024 Sep 16.
4
Retraction.撤回。
Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809. Epub 2023 May 22.
5
Retraction: Tongyi Lu, Binhua Wu, Yunfei Yu, Wenhui Zhu, Simin Zhang, Yinmei Zhang, Jiaying Guo, Ning Deng. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018; 109: 2221-2234. https://doi.org/10.1111/cas.13633.撤稿声明:陆通一、吴炳华、余云飞、朱文慧、张思敏、张银梅、郭嘉莹、邓宁。卵巢癌中ONECUT2表达的阻断抑制肿瘤细胞增殖、迁移、侵袭和血管生成。《癌症科学》。2018年;109: 2221 - 2234。https://doi.org/10.1111/cas.13633 。
Cancer Sci. 2024 Apr;115(4):1360. doi: 10.1111/cas.16108. Epub 2024 Feb 11.
6
RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.撤回声明:微小RNA-16通过抑制BCL2以及核因子-κB1/基质金属蛋白酶-9信号通路来抑制胶质瘤细胞的生长和侵袭。
Cancer Sci. 2024 Sep;115(9):3200. doi: 10.1111/cas.16269. Epub 2024 Jul 22.
7
RETRACTION: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor-κB-Induced Matrix Metalloproteinase 2 Expression.撤稿声明:碳酸酐酶4是临床预后不良的标志物,并通过核因子κB诱导的基质金属蛋白酶2表达促进鼻咽癌转移。
Cancer Sci. 2024 Oct;115(10):3491. doi: 10.1111/cas.16305. Epub 2024 Aug 5.
8
Retraction Statement: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.撤稿声明:外泌体miR-1255b-5p靶向结直肠癌细胞中的人端粒酶逆转录酶以抑制上皮-间质转化
Mol Oncol. 2023 Jul;17(7):1454. doi: 10.1002/1878-0261.13452. Epub 2023 May 25.
9
Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.撤稿声明:长链非编码RNA-ROR通过靶向miR-206促进骨肉瘤进展。
J Cell Mol Med. 2024 Mar;28(6):e18199. doi: 10.1111/jcmm.18199.
10
Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation.外泌体 miR-106a-5p 通过 FBXW7 介导的 TRIM24 降解加速鼻咽癌的进展。
Cancer Sci. 2022 May;113(5):1652-1668. doi: 10.1111/cas.15337. Epub 2022 Mar 29.

撤稿声明:外泌体miR-106a-5p通过FBXW7介导的TRIM24降解加速鼻咽癌进展。

RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation.

出版信息

Cancer Sci. 2024 Nov;115(11):3829. doi: 10.1111/cas.16312. Epub 2024 Aug 21.

DOI:10.1111/cas.16312
PMID:39166827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531962/
Abstract

C.-W. Li, J. Zheng, G.-Q. Deng, Y.-G. Zhang, Y. Du and H.-Y. Jiang, "Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation," Cancer Science 113, no. 5 (2022): 1652-1668, https://doi.org/10.1111/cas.15337. The above article, published online on 16 March 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia, Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed that images of pathological results were duplicated across other articles in a different scientific context. The authors acknowledge the duplication of the images and apologise for the errors. Despite the authors providing all original data and reconducting the animal pathology experiments, given the extent and nature of duplications found, the editors consider the results and conclusion of this article to be invalid.

摘要

李崇武、郑洁、邓国清、张义刚、杜阳和姜海岩,“外泌体miR-106a-5p通过FBXW7介导的TRIM24降解促进鼻咽癌进展”,《癌症科学》113卷,第5期(2022年):1652 - 1668页,https://doi.org/10.1111/cas.15337 。上述文章于2022年3月16日在线发表于威利在线图书馆(wileyonlinelibrary.com),经作者、期刊主编畠山正宪、日本癌症协会以及约翰·威利父子澳大利亚有限公司协商一致后予以撤稿。撤稿是在对第三方提出的担忧进行调查之后达成的,调查发现病理结果图像在不同科学背景下的其他文章中被重复使用。作者承认图像重复并为错误致歉。尽管作者提供了所有原始数据并重新进行了动物病理学实验,但鉴于所发现重复的程度和性质,编辑认为本文的结果和结论无效。